Anahtar KelimelerEpikardiyal Yağ Dokusu; Koroner Arter Hastalığı; Koroner Plak Abstract Aim: Epicardial adipose tissue (EAT) contributes to the development and progression of coronary artery disease (CAD). We aimed to evaluate the relationship between EAT volume, coronary atherosclerosis, coronary plaque burden, and plaque structure in diabetic patients. Material and Method: 196 DM patients who were evaluated with 128-slice dual-source coronary computed tomography angiography (CCTA) for suspected CAD were included in the study. The CCTA examination was used to assess the total plaque burden, number of diseased segments, plaque characteristics, and EAT volume. The study population was divided into two groups [a CAD group (Group I) and non-CAD group (Group II)]. The plaque characteristics were analyzed on a per-segment basis. Results: EAT volume was found to be significantly higher among diabetic patients with CAD compared to those without CAD ( 138.7±49.1 ml vs 98.6±34.7 ml, p<0.001). In the correlation analysis, EAT volume showed significant positive correlation with BMI (r=0.369, p<0.001), total plaque burden (r=0.424, p<0.001), mixed plaques (r=0.454, p<0.001), non-calcified plaques (r=0.369, p<0.001), calcified plaques (r=0.191, p=0.007), and number of diseased segments (r=0.449, p<0.001). Also, multivariate logistic-regression analysis revealed that EAT volume to be a significant and independent predictor of the presence of CAD in patients with DM (OR=1.023, 95% CI: 1.014-1.032; p<0.001). Discussion: We have determined that EAT volume is an independent predictor among diabetic patients for the presence of CAD. Moreover, EAT volume showed moderate correlation with total plaque burden and the number of mixed and non-calcified plaques but weak correlation with calcified plaques.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.